Literature DB >> 28177141

Coupling of Bone Resorption and Formation in Real Time: New Knowledge Gained From Human Haversian BMUs.

Nicolai Ernlund Lassen1, Thomas Levin Andersen1, Gro Grunnet Pløen1, Kent Søe1, Ellen Margrethe Hauge2, Søren Harving3, Gete Ester Toft Eschen4, Jean-Marie Delaisse1.   

Abstract

It is well known that bone remodeling starts with a resorption event and ends with bone formation. However, what happens in between and how resorption and formation are coupled remains mostly unknown. Remodeling is achieved by so-called basic multicellular units (BMUs), which are local teams of osteoclasts, osteoblasts, and reversal cells recently proven identical with osteoprogenitors. Their organization within a BMU cannot be appropriately analyzed in common histology. The originality of the present study is to capture the events ranging from initiation of resorption to onset of formation as a functional continuum. It was based on the position of specific cell markers in longitudinal sections of Haversian BMUs generating new canals through human long bones. It showed that initial resorption at the tip of the canal is followed by a period where newly recruited reversal/osteoprogenitor cells and osteoclasts alternate, thus revealing the existence of a mixed "reversal-resorption" phase. Three-dimensional reconstructions obtained from serial sections indicated that initial resorption is mainly involved in elongating the canal and the additional resorption events in widening it. Canal diameter measurements show that the latter contribute the most to overall resorption. Of note, the density of osteoprogenitors continuously grew along the "reversal/resorption" surface, reaching at least 39 cells/mm on initiation of bone formation. This value was independent of the length of the reversal/resorption surface. These observations strongly suggest that bone formation is initiated only above a threshold cell density, that the length of the reversal/resorption period depends on how fast osteoprogenitor recruitment reaches this threshold, and thus that the slower the rate of osteoprogenitor recruitment, the more bone is degraded. They lead to a model where the newly recognized reversal/resorption phase plays a central role in the mechanism linking osteoprogenitor recruitment and the resorption-formation switch.
© 2017 American Society for Bone and Mineral Research. © 2017 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE HISTOMORPHOMETRY; BONE REMODELING; HUMAN; OSTEOBLAST; OSTEOCLAST

Mesh:

Year:  2017        PMID: 28177141     DOI: 10.1002/jbmr.3091

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  30 in total

Review 1.  Coupling factors involved in preserving bone balance.

Authors:  Beom-Jun Kim; Jung-Min Koh
Journal:  Cell Mol Life Sci       Date:  2018-12-04       Impact factor: 9.261

2.  Absence of an osteopetrosis phenotype in IKBKG (NEMO) mutation-positive women: A case-control study.

Authors:  Morten Frost; Michaela Tencerova; Christina M Andreasen; Thomas L Andersen; Charlotte Ejersted; Dea Svaneby; Weimin Qui; Moustapha Kassem; Allahdad Zarei; William H McAlister; Deborah J Veis; Michael P Whyte; Anja L Frederiksen
Journal:  Bone       Date:  2019-01-16       Impact factor: 4.398

Review 3.  Bone remodeling: an operational process ensuring survival and bone mechanical competence.

Authors:  Simona Bolamperti; Isabella Villa; Alessandro Rubinacci
Journal:  Bone Res       Date:  2022-07-18       Impact factor: 13.362

Review 4.  The origins and roles of osteoclasts in bone development, homeostasis and repair.

Authors:  Yasuhito Yahara; Tuyet Nguyen; Koji Ishikawa; Katsuhiko Kamei; Benjamin A Alman
Journal:  Development       Date:  2022-05-03       Impact factor: 6.862

5.  Identification of a 22 bp DNA cis Element that Plays a Critical Role in Colony Stimulating Factor 1-Dependent Transcriptional Activation of the SPHK1 Gene.

Authors:  Gang Qing Yao; Meiling Zhu; Joanne Walker; Karl Insogna
Journal:  Calcif Tissue Int       Date:  2020-04-03       Impact factor: 4.333

6.  Disturbance of osteonal bone remodeling and high tensile stresses on the lateral cortex in atypical femoral fracture after long-term treatment with Risedronate and Alfacalcidol for osteoporosis.

Authors:  Fumitaka Hirano; Kayoko Furukawa Okuma; Yukichi Zenke; Kunitaka Menuki; Hideo Ohnishi; Fumio Fukuda; Akinori Sakai; Noriaki Yamamoto; Taketoshi Shimakura; Hiroshige Sano; Yuta Tokunaga; Hideaki E Takahashi
Journal:  Bone Rep       Date:  2021-05-07

Review 7.  Osteon: Structure, Turnover, and Regeneration.

Authors:  Bei Chang; Xiaohua Liu
Journal:  Tissue Eng Part B Rev       Date:  2021-03-08       Impact factor: 7.376

8.  KIAA1199 is a secreted molecule that enhances osteoblastic stem cell migration and recruitment.

Authors:  Li Chen; Kaikai Shi; Thomas Levin Andersen; Weimin Qiu; Moustapha Kassem
Journal:  Cell Death Dis       Date:  2019-02-12       Impact factor: 8.469

9.  Innervation is higher above Bone Remodeling Surfaces and in Cortical Pores in Human Bone: Lessons from patients with primary hyperparathyroidism.

Authors:  Manasi Sayilekshmy; Rie Bager Hansen; Jean-Marie Delaissé; Lars Rolighed; Thomas Levin Andersen; Anne-Marie Heegaard
Journal:  Sci Rep       Date:  2019-03-29       Impact factor: 4.379

10.  A network of trans-cortical capillaries as mainstay for blood circulation in long bones.

Authors:  Anika Grüneboom; Ibrahim Hawwari; Daniela Weidner; Stephan Culemann; Sylvia Müller; Sophie Henneberg; Alexandra Brenzel; Simon Merz; Lea Bornemann; Kristina Zec; Manuela Wuelling; Lasse Kling; Mike Hasenberg; Sylvia Voortmann; Stefanie Lang; Wolfgang Baum; Alexandra Ohs; Oliver Kraff; Harald H Quick; Marcus Jäger; Stefan Landgraeber; Marcel Dudda; Renzo Danuser; Jens V Stein; Manfred Rohde; Kolja Gelse; Annette I Garbe; Alexandra Adamczyk; Astrid M Westendorf; Daniel Hoffmann; Silke Christiansen; Daniel Robert Engel; Andrea Vortkamp; Gerhard Krönke; Martin Herrmann; Thomas Kamradt; Georg Schett; Anja Hasenberg; Matthias Gunzer
Journal:  Nat Metab       Date:  2019-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.